0001213900-22-006017.txt : 20220314 0001213900-22-006017.hdr.sgml : 20220314 20220209061054 ACCESSION NUMBER: 0001213900-22-006017 CONFORMED SUBMISSION TYPE: CORRESP PUBLIC DOCUMENT COUNT: 2 FILED AS OF DATE: 20220209 FILER: COMPANY DATA: COMPANY CONFORMED NAME: InMed Pharmaceuticals Inc. CENTRAL INDEX KEY: 0001728328 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: A1 FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: CORRESP BUSINESS ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 BUSINESS PHONE: (604) 669-7207 MAIL ADDRESS: STREET 1: SUITE 310, 815 W. HASTINGS STREET CITY: VANCOUVER STATE: A1 ZIP: V6C 1B4 CORRESP 1 filename1.htm

February 9, 2022

VIA EDGAR
United States Securities and Exchange Commission
Division of Corporation Finance

Office of Life Sciences
100 F Street, N.E.
Washington, D.C. 20549

Re:

InMed Pharmaceuticals Inc.

Registration Statement on Form S-3

Filed February 4, 2022

File No. 333-262533

Ladies and Gentlemen:

On behalf of InMed Pharmaceuticals Inc., a British Columbia corporation (the “Company”), the undersigned hereby respectfully submits its request for acceleration of effectiveness. Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, the undersigned hereby requests that the effective date of the above referenced Registration Statement on Form S-3 (the “Registration Statement”), be accelerated so that the same will become effective at 4:00 p.m., Washington, D.C. time, on Friday, February 11, 2022, or as soon as practicable thereafter.

Please notify Brian P. Fenske of Norton Rose Fulbright US LLP, counsel to the Company, at (713) 651-5557, as soon as the Registration Statement has been declared effective, or if you have any other questions or concerns regarding this matter.

	Very truly yours,

	InMed Pharmaceuticals Inc.
	By:	/s/ Eric A. Adams
	Name:	Eric A. Adams
	Title:	President and Chief Executive Officer

GRAPHIC 2 image_001.jpg GRAPHIC begin 644 image_001.jpg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end